Effect of Hydration With Sodium Bicarbonate for Long-Term Clinical Outcomes in Patients With Chronic Kidney Disease Undergoing an Emergent Coronary Procedure

Status

UNKNOWN

Phases

Phase 4

Study type

Interventional

Source

ClinicalTrials.gov

Registry ID

NCT00716001

Enrollment

Unknown

Registered

2008-07-15

Start date

2008-07-31

Completion date

Unknown

Last updated

2008-07-15

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Chronic Renal Failure

Keywords

patients with chronic renal failure undergoing elective percutaneous coronary intervention

Brief summary

This study is to evaluate the efficacy of sodium bicarbonate plus N-acetylcysteine for the prevention of contrast-induced nephropathy.

Interventions

DRUGN-acetylcysteine

Study design

Allocation

RANDOMIZED

Intervention model

PARALLEL

Masking

NONE

Eligibility

Sex/Gender

ALL

Age

20 Years to No maximum

Healthy volunteers

Inclusion criteria

* patients with chronic renal failure(serum creatinine \>1.1mg/dl) undergoing elective percutaneous coronary intervention

Exclusion criteria

* administered with sodium bicarbonate and/or N-acetylcysteine and/or contrast media within 72 hours. * pregnancy * congestive heart failure * allergy to sodium bicarbonate and/or N-acetylcysteine * hemodialysis

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026